Sagard NewGen

Overview

Sagard NewGen is a European private equity firm that focuses on investing in high-growth technology and healthcare companies. The firm seeks to support entrepreneurs in these sectors by providing capital and expertise to accelerate their growth strategies. Sagard NewGen typically makes majority or minority investments ranging from €10 million to €50 million, targeting profitable companies with revenues between €10 million and €150 million. The firm operates across various European countries, including France, Germany, the United Kingdom, Italy, Spain, and others. The firm's investment strategy is centered on partnering with management teams to drive expansion and value creation. Sagard NewGen offers tailored solutions, both in terms of investment horizon and financial structure, to meet the specific needs of each portfolio company. The firm emphasizes an entrepreneurial approach and works closely with management teams to ensure rapid decision-making aligned with the pace of business activity. Sagard NewGen is part of Sagard, a global multi-strategy alternative asset management firm with over $33 billion in assets under management. Sagard has a presence in Canada, the United States, Europe, and the Middle East, and invests across various asset classes, including venture capital, private equity, private credit, and real estate. The firm's extensive network and resources enable it to provide comprehensive support to its portfolio companies, fostering long-term growth and success.

Investment Focus

• Profitable European companies with revenues up to €150 million
• Commitment to innovation and sustainability
• Profitable companies with revenues between €10 million and €150 million
• Operating in the technology or healthcare sectors
• Seeking expansion capital

Portfolio Companies